Bio-Path Holdings (NASDAQ: BPTH) reported Q3 EPS of ($0.02), $0.01 worse than the analyst estimate of ($0.01).

As of September 30, 2016, the Company had cash of $11.3 million, compared to $8.9 million at December 31, 2015. Net cash used in operating activities for the nine months ended June 30, 2016 was $6.5 million compared to $4.0 million for the comparable period in 2015.

For earnings history and earnings-related data on Bio-Path Holdings (BPTH) click here.